Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-09-30 00:00:00 ET · period of report 2022-08-16 · accession 0001209191-22-051665 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-09-30	2022-08-16+	CPIX	Krogulski Kenneth	Dir	P - Purchase	$2.44	+3,280	195.8K	+2%	+$7,996

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-09-09	P	A	60	$2.21	195,870	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
2	Common	Common Stock	2022-09-12	P	A	115	$2.46	195,985	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
3	Common	Common Stock	2022-09-13	P	A	115	$2.45	196,100	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
4	Common	Common Stock	2022-09-14	P	A	115	$2.51	196,215	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
5	Common	Common Stock	2022-09-15	P	A	115	$2.47	196,330	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
6	Common	Common Stock	2022-09-16	P	A	115	$2.49	196,445	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
7	Common	Common Stock	2022-09-19	P	A	105	$2.56	196,550	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
8	Common	Common Stock	2022-09-20	P	A	105	$2.54	196,655	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
9	Common	Common Stock	2022-09-21	P	A	105	$2.59	196,760	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
10	Common	Common Stock	2022-09-22	P	A	105	$2.51	196,865	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
11	Common	Common Stock	2022-09-23	P	A	105	$2.55	196,970	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
12	Common	Common Stock	2022-09-26	P	A	105	$2.49	197,075	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
13	Common	Common Stock	2022-09-27	P	A	105	$2.57	197,180	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
14	Common	Common Stock	2022-08-16	P	A	110	$2.35	194,010	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
15	Common	Common Stock	2022-08-17	P	A	110	$2.31	194,120	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
16	Common	Common Stock	2022-08-18	P	A	110	$2.23	194,230	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
17	Common	Common Stock	2022-08-19	P	A	110	$2.35	194,340	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
18	Common	Common Stock	2022-08-22	P	A	110	$2.51	194,450	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
19	Common	Common Stock	2022-08-23	P	A	110	$2.59	194,560	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
20	Common	Common Stock	2022-08-24	P	A	110	$2.59	194,670	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
21	Common	Common Stock	2022-08-25	P	A	110	$2.62	194,780	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
22	Common	Common Stock	2022-08-26	P	A	110	$2.55	194,890	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
23	Common	Common Stock	2022-08-29	P	A	115	$2.44	195,005	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
24	Common	Common Stock	2022-08-30	P	A	115	$2.38	195,120	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
25	Common	Common Stock	2022-08-31	P	A	115	$2.36	195,235	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
26	Common	Common Stock	2022-09-01	P	A	115	$2.39	195,350	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
27	Common	Common Stock	2022-09-02	P	A	115	$2.42	195,465	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
28	Common	Common Stock	2022-09-06	P	A	115	$2.15	195,580	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
29	Common	Common Stock	2022-09-07	P	A	115	$2.24	195,695	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
30	Common	Common Stock	2022-09-08	P	A	115	$2.22	195,810	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.